Literature DB >> 9575686

Four cases of pustulotic arthro-osteitis.

K A Jang1, K J Sung, K C Moon, J K Koh, J H Choi.   

Abstract

We describe four cases of pustulotic arthro-osteitis. All of them suffered from anterior chest wall symptoms, such as swelling and pain on the sternoclavicular joint, sternal angle area, sternocostal joint, and costochondral junction. Although chest X-ray findings were all normal, 99mTc-scintigraphy revealed increased uptake in the affected areas in all cases. Laboratory examinations including rheumatoid factor were negative or normal except for elevation of the erythrocyte sedimentation rate and C-reactive protein in 2 cases. After treatment with non-steroidal anti-inflammatory drugs and etretinate or topical PUVA, the skin lesions on the palms and soles and the arthro-osteitis were moderately improved. Pustulotic arthro-osteitis should be considered when a patient with pustulosis palmoplantaris complains of anterior chest wall pain and other joint pain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575686     DOI: 10.1111/j.1346-8138.1998.tb02381.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

Review 1.  SAPHO syndrome--a pictorial assay.

Authors:  Lokesh Khanna; Georges Y El-Khoury
Journal:  Iowa Orthop J       Date:  2012

Review 2.  Sonozaki syndrome: case report and review of literature.

Authors:  Ligia Brzezińska-Wcisło; Beata Bergler-Czop; Anna Lis-Święty
Journal:  Rheumatol Int       Date:  2010-01-05       Impact factor: 2.631

3.  Pustulotic arthro-osteitis (sonozaki syndrome).

Authors:  Ozlem Su; Serpil Pirmit; Dilek Biyik Ozkaya; Yasemin Balsever Kural; Nahide Onsun
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

4.  Efficacy of guselkumab in a subpopulation with pustulotic arthro-osteitis through week 52: an exploratory analysis of a phase 3, randomized, double-blind, placebo-controlled study in Japanese patients with palmoplantar pustulosis.

Authors:  T Yamamoto; K Fukuda; A Morita; T Kimura; H Morishima; R Goto; R Zheng; T Terui
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.